Invitae, a leading medical genetics company, announced a partnership with BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, designed...
Invitae, a leading medical genetics company, announced new research published in Nature describing the first use of the company's personalized cancer monitoring (PCM) platform to...
